maanantai, 28. syyskuu 2026

Ioversol

 

Ioversol

CAS No.: 87771-40-2

 

Molecular formula: C18H24I3N3O9

 

Molecular Weight: 807.11

 

Quality standard: CP, USP

 

Characteristics: White or almost white powder

 

Content (HPLC): ≥99.0%

 

Packing: 25KG, 50KG/drum

 

Storage: Protected from light, sealed tightly

 

As a professional contrast media manufacturer, beijing beilu pharmaceutical co ltd has high-quality ct contrast media for sale. Welcome to contact us if needed.

4.jpg

maanantai, 28. syyskuu 2026

Gadopentetate Dimeglumine Injection/API

 

Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, and quickly occupied the market with its excellent quality and reasonable price. Up to now, linear gadolinium has been safely used for nearly 30 years, with excellent enhancement effects and few side effects. Beilu also produces gadobutrol injection with high quality and reasonable price, contact us for more info!

 

 

 

Product name: Gadopentetate Dimeglumine Injection

 

Generic name: Gadopentetate Dimeglumine Injection

 

Type: Injectable Contrast Media for MRI, Linear Contrast Media

 

No.1 market share in China

 

Specification: 20ml:9.38 g(469mg/ml, 20ml)

 

                               15ml:7.04 g(469mg/ml, 15ml)

 

                               12ml:5.63 g(469mg/ml, 12ml)

 

                               10ml:4.69 g(469mg/ml, 10ml)

 

Indication: MRI

 

Active Ingredients: Gadopentetate Dimeglumine

 

Standard: USP/EP/CP

 

Posology and method of administration: Intravenous injection

 

Adverse reactions: See the details from the package insert

 

Shelf life: 36 months

 

Indication of Gadopentetate Dimeglumine Injection

Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.

 

Precautions of Gadopentetate Dimeglumine Injection

1. Use with caution in patients with severe kidney damage, epilepsy, hypotension, asthma and other allergic respiratory diseases and those with allergic tendencies.

 

2. Take care to avoid the extravasation of the Gadopentetic acid liquid during injection to prevent tissue pain.

 

3. The serum iron and bilirubin levels of some patients will increase slightly after medication, but they are asymptomatic and can return to normal within 24 hours.

 

4. Pregnant women and breastfeeding women should use it with caution. Animal experiments show that a small amount of medicine liquid enters the milk.

 

 

5. The effective enhancement time of Magnevist contrast is 45 minutes. MRI examination should be performed immediately after intravenous injection.

 

6. The remaining medicine liquid after one examination should not be used again.

 

7. When applying this type of MRI contrast media, follow the relevant safety regulations in magnetic resonance imaging.

 

8. GBCAs should be used with caution. When plain scan MRI cannot obtain the corresponding vital diagnostic information, GBCAs can be used, and the lowest approved dose is used as much as possible.

 

9. Gadolinium deposition

 

Current evidence shows that after repeated use of GBCAs, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic.

 

The clinical significance of brain gadolinium deposition is unclear.

 

In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.

 

As a professional contrast media manufacturer, bei lu has high-quality ct contrast media for sale. Welcome to contact us if needed.

2.jpg

maanantai, 28. syyskuu 2026

Glimepiride Tablets

 

glimepiride 1mg tablets  is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, Glimepiride tablets (Dibei), as the first hypoglycemic product of Beilu Pharma, was first listed in China and belongs to the second class of national new drugs.

 

Product name: Glimepiride Tablets

Specifications: glimepiride tab 1mg×30 tablets;glimepiride 2 mg×15 tablets;glimepiride 2mg×30 tablets

 

Characteristics: White tablet

 

Indications :

 

As one of the oral antidiabetic drugs produced by Beilu Pharma, our glimepiride tablets are only suitable for type 2 diabetes that cannot fully control blood sugar through diet control, exercise therapy and weight loss.

 

glimepiride 2 tablet  are not suitable for type 1 diabetes (for example, the treatment of diabetic patients with a history of ketoacidosis), diabetic ketoacidosis or Treatment of pre-diabetic coma or coma.

 

Usage and Dosage: Please refer to the glimepiride package insert

 

Adverse reactions, Contraindications, Precautions: Please refer to the package insert.

 

Storage: Shade, seal, and keep in a dry place.

 

Packaging: Aluminum plastic packaging, 15 pills/plate, 1 plate/box; 15 pills/plate, 2 plates/box.

 

Shelf life: 24 months

 

 

 

Advantages of Glimepiride Tablets

Double effect directly hit the hypoglycemic core

 

Double effect: Glimepiride tablets can promote insulin secretion and improve insulin resistance. At the same time, it can improve the two major pathophysiological abnormalities of insulin secretion and insulin resistance in patients with type 2 diabetes.

 

Efficiently reduce postprandial blood glucose, fasting blood glucose and glycosylated haemoglobin

 

Glimepiride tablets monotherapy can comprehensively reduce FPG PPG and HbA1c in newly diagnosed T2DM patients

 

Combination therapy, such as combined metformin, acarbose, etc., has a more significant overall hypoglycemic effect

 

Less hypoglycemia, less weight impact, high safety

 

Short-term treatment, the risk of glimepiride hypoglycemia is only 1/3 of that of Glibenclamide

 

Long-term treatment, the risk of glimepiride hypoglycemia is only 1/7of that of Glibenclamide

 

Glimepiride has a small impact on the weight of T2DM patients

 

Once a day to improve patient compliance

 

If the patient's compliance is poor, Glimepiride tablets should be selected, once a day.

 

For more information about glimepiride 2mg tablets used for  and side effects of glimepiride 1mg tablet, please feel free to contact us!

 

As a professional contrast media manufacturer, Beilu has high-quality ct contrast media for sale. Welcome to contact us if needed.

3.jpg

maanantai, 28. syyskuu 2026

Gadobutrol Injection/API

 

In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contrast Medium used in various parts of the body lesion (including the brain and spinal cord) MRI imaging and angiography examination. Its macrocyclic nature ensures it is well-tolerated with a good safety profile for MRI Contrast. As a professional contrast media manufacturer, Beilu can provide you with the high concentration gadobutrol gadovist that leads to a better image with lower volume. We also provide DTPA acid with high quality.

 

Product name: gadubutrol Injection

 

Generic name: gadobutrol Injection

 

Type: Injectable Contrast Media for MRI, Macrocyclic Contrast Media

 

Specification: 7.5 ml:4.5354 g(604.72mg/ml 7.5ml );

                               15ml:9.0708g(604.72mg/ml 15ml )

Indication:MRI

 

Active Ingredients: Gadobutrol

 

Standard: USP/EP/CP

 

Administration: Intravenous administration only.

 

Adverse reactions: See the details from the package insert.

 

Shelf life: 36 months

 

Indication of Gadopentetate Dimegumine Injection

Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.

 

Precautions of Gadopentetate Dimegumine Injection

1. Use with caution in patients with severe kidney damage, epilepsy, hypotension, asthma and other allergic respiratory diseases and those with allergic tendencies.

 

2. Pay attention to avoid the extravasation of the liquid during the gadovist 7.5 ml uses so as to prevent tissue pain.

 

 

 

3. The serum iron and bilirubin levels of some patients will increase slightly after medication, but they are asymptomatic and can return to normal within 24 hours.

 

4. Pregnant women and breastfeeding women should use it with caution. Animal experiments show that a small amount of medicine liquid enters the milk.

 

5. The effective enhancement time of this product is 45 minutes. MRI examination should be performed immediately after intravenous injection.

 

6. The remaining medicine liquid after one examination should not be used again.

 

7. When gadovist dose, follow the relevant safety regulations in magnetic resonance imaging.

 

8. GBCAs should be used with caution. When plain scan MRI cannot obtain the corresponding vital diagnostic information, GBCAs can be used, and the lowest approved dose is used as much as possible.

 

9. Gadolinium deposition

 

Current evidence shows that after repeated use of GBCAs, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic.

 

The clinical significance of brain gadolinium deposition is unclear.

 

In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.

 

For gadobutrol injection uses, contact us.

 

As a professional contrast media manufacturer, beijing pharmaceuticals has high-quality ct contrast media for sale. Welcome to contact us if needed.

 

 

1.jpg

maanantai, 28. syyskuu 2026

Moikka maailma!

Onnittelut uudesta blogistasi!

Tämä on esimerkkiartikkeli. Uutta sisältöä voit luoda blogin hallinnan kautta. Voit poistaa tämän artikkelin artikkeliarkiston kautta.